Recursion Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
ARK INVESTMENT MANAGEMENT LLC | 10/31/2024 | 32.77 M | $215.95 M | 16.44% | 11.60% |
BAILLIE GIFFORD & CO | 11/05/2024 | 25.24 M | $166.33 M | -5.08% | 8.93% |
VANGUARD GROUP INC | 11/13/2024 | 24.27 M | $159.96 M | 12.60% | 8.59% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 20.74 M | $136.70 M | 100.00% | 7.34% |
RA CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 15.38 M | $101.38 M | 0.00% | 5.44% |
MUBADALA INVESTMENT CO PJSC | 11/13/2024 | 12.99 M | $85.58 M | 0.00% | 4.60% |
STATE STREET CORP | 11/14/2024 | 12.87 M | $84.82 M | 47.10% | 4.55% |
KINNEVIK AB (PUBL) | 10/15/2024 | 11.91 M | $78.46 M | 0.00% | 4.21% |
SUMITOMO MITSUI TRUST HOLDINGS, INC. | 11/05/2024 | 9.77 M | $64.36 M | -2.21% | 3.46% |
NIKKO ASSET MANAGEMENT AMERICAS, INC. | 11/07/2024 | 9.69 M | $63.89 M | -2.41% | 3.43% |
MIC CAPITAL MANAGEMENT UK LLP | 11/14/2024 | 8.45 M | $55.70 M | 0.00% | 2.99% |
FMR LLC | 11/13/2024 | 8.36 M | $55.12 M | 2.08% | 2.96% |
NVIDIA CORP | 11/14/2024 | 7.71 M | $50.78 M | 0.00% | 2.73% |
DATA COLLECTIVE IV GP, LLC | 11/14/2024 | 5.94 M | $39.15 M | 0.00% | 2.10% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 5.43 M | $35.80 M | 13.74% | 1.92% |
DCVC OPPORTUNITY FUND II GP, LLC | 11/14/2024 | 3.95 M | $26.04 M | 0.00% | 1.40% |
EXOR CAPITAL LLP | 11/13/2024 | 3.68 M | $24.22 M | 0.00% | 1.30% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2024 | 2.32 M | $15.26 M | 100.00% | 0.82% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 1.94 M | $12.79 M | 17.49% | 0.69% |
MORGAN STANLEY | 11/14/2024 | 1.88 M | $12.37 M | 6.16% | 0.66% |
DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 1.72 M | $11.32 M | -10.54% | 0.61% |
TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 1.60 M | $10.53 M | 11.99% | 0.57% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.54 M | $10.15 M | 43.82% | 0.54% |
JPMORGAN CHASE & CO | 12/26/2024 | 1.18 M | $7.75 M | 6.08% | 0.42% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 1.17 M | $7.68 M | -36.71% | 0.41% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 1.12 M | $7.41 M | 49.81% | 0.40% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 1.07 M | $7.05 M | -21.73% | 0.38% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 1.01 M | $6.65 M | -19.62% | 0.36% |
LIONTRUST INVESTMENT PARTNERS LLP | 10/16/2024 | 990,000 | $7.43 M | 0.00% | 0.35% |
VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 973,583 | $6.42 M | 100.00% | 0.34% |
COMPREHENSIVE FINANCIAL MANAGEMENT LLC | 11/14/2024 | 941,895 | $6.21 M | 0.00% | 0.33% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 926,118 | $6.10 M | -12.70% | 0.33% |
UBS GROUP AG | 11/14/2024 | 799,860 | $5.27 M | -51.50% | 0.28% |
VESTMARK ADVISORY SOLUTIONS, INC. | 11/14/2024 | 732,933 | $4.83 M | -6.62% | 0.26% |
BARCLAYS PLC | 11/19/2024 | 697,432 | $4.60 M | 77.39% | 0.25% |
CERCANO MANAGEMENT LLC | 11/14/2024 | 685,018 | $4.51 M | 0.00% | 0.24% |
RAFFERTY ASSET MANAGEMENT, LLC | 11/13/2024 | 675,791 | $4.45 M | 52.12% | 0.24% |
WOODLINE PARTNERS LP | 11/14/2024 | 671,319 | $4.42 M | 1.03% | 0.24% |
LAZARD ASSET MANAGEMENT LLC | 11/14/2024 | 642,308 | $4.23 M | 22.54% | 0.23% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 591,500 | $3.90 M | 94.89% | 0.21% |
CITADEL ADVISORS LLC | 11/14/2024 | 556,700 | $3.67 M | 1.20% | 0.20% |
TWINBEECH CAPITAL LP | 11/14/2024 | 535,079 | $3.53 M | 44.13% | 0.19% |
TWO SIGMA ADVISERS, LP | 11/14/2024 | 489,900 | $3.23 M | 12.41% | 0.17% |
ENSIGN PEAK ADVISORS, INC | 11/14/2024 | 408,986 | $2.70 M | 0.00% | 0.14% |
BELLEVUE GROUP AG | 11/14/2024 | 392,881 | $2.59 M | -7.73% | 0.14% |
LPL FINANCIAL LLC | 11/08/2024 | 360,438 | $2.38 M | 12.82% | 0.13% |
SWISS NATIONAL BANK | 11/07/2024 | 357,100 | $2.35 M | 0.53% | 0.13% |
RHUMBLINE ADVISERS | 11/12/2024 | 310,468 | $2.05 M | 10.35% | 0.11% |
CITADEL ADVISORS LLC | 11/14/2024 | 299,300 | $1.97 M | 16.73% | 0.11% |
SIMPLEX TRADING, LLC | 11/08/2024 | 284,713 | $1.88 M | 200.42% | 0.10% |
Recursion Pharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 316 institutional investors and hedge funds held shares of Recursion Pharmaceuticals, Inc.. The most heavily invested institutionals were:
ARK Investment Management LLC: 32.77 M
BAILLIE GIFFORD & CO: 25.24 M
VANGUARD GROUP INC: 24.27 M
BlackRock Funding, Inc. /DE: 20.74 M
RA CAPITAL MANAGEMENT, L.P.: 15.38 M
Mubadala Investment Co PJSC: 12.99 M
92.33% of Recursion Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 284.90 M shares in the last 24 months. This purchase volume represents approximately $2.07 B in transactions.